Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis

Abstract is missing (Short communication)

[1]  K. Ali,et al.  First-Trimester Impetigo Herpetiformis Leads to Stillbirth: A Case Report , 2022, Dermatology and Therapy.

[2]  C. Nelson,et al.  Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US. , 2022, JAMA dermatology.

[3]  M. Rizwan,et al.  Acute Generalized Exanthematous Pustulosis Induced by Cetuximab , 2021, Cureus.

[4]  S. Tavakolpour,et al.  Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus , 2021, International journal of dermatology.

[5]  M. P. Gibson,et al.  Inhibition of neutrophil inflammatory mediator expression by azithromycin , 2020, Clinical Oral Investigations.

[6]  Bhanu Pratap Singh Rawat,et al.  Inferring ADR causality by predicting the Naranjo Score from Clinical Notes , 2020, AMIA.

[7]  A. Porro,et al.  Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  G. Peng,et al.  Glycyrrhizin ameliorates atopic dermatitis‐like symptoms through inhibition of HMGB1 , 2018, International immunopharmacology.

[9]  C. Xue,et al.  Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials , 2017, Current medical research and opinion.

[10]  R. Schwartz,et al.  Acute generalized exanthematous pustulosis (AGEP): A review and update. , 2015, Journal of the American Academy of Dermatology.

[11]  J. Valença,et al.  Acute Generalized Exanthematous Pustulosis in a 51-Year-Old Patient under Etanercept Treatment for Psoriasis , 2014 .

[12]  İ. Zindancı,et al.  Acute Generalized Exanthematous Pustulosis Induced by Etanercept: Another Dermatologic Adverse Effect , 2013, Case reports in dermatological medicine.

[13]  G. Tobón,et al.  Acute Generalized Exanthematous Pustulosis due to Tocilizumab in a Rheumatoid Arthritis Patient , 2012, Case reports in rheumatology.

[14]  R. Stern.  Clinical practice. Exanthematous drug eruptions. , 2012, The New England journal of medicine.

[15]  L. Naldi,et al.  Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR) , 2007, The British journal of dermatology.